home / stock / sldb / sldb quote
Last: | $5.96 |
---|---|
Change Percent: | 1.44% |
Open: | $6.18 |
Close: | $5.96 |
High: | $6.34 |
Low: | $5.735 |
Volume: | 661,821 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$5.96 | $6.18 | $5.96 | $6.34 | $5.735 | 661,821 | 07-02-2024 |
$6.27 | $5.94 | $6.27 | $6.39 | $5.75 | 1,017,430 | 07-01-2024 |
$5.67 | $5.77 | $5.67 | $6.03 | $5.54 | 4,378,149 | 06-28-2024 |
$5.74 | $5.7 | $5.74 | $6.08 | $5.5401 | 626,894 | 06-27-2024 |
$5.7 | $5.8 | $5.7 | $5.83 | $5.2101 | 939,015 | 06-26-2024 |
$5.8 | $6.6 | $5.8 | $6.6 | $5.61 | 2,066,989 | 06-25-2024 |
$6.62 | $6.67 | $6.62 | $6.725 | $6.43 | 666,845 | 06-24-2024 |
$6.46 | $7.15 | $6.46 | $7.398 | $6.11 | 2,992,703 | 06-21-2024 |
$6.3 | $6.72 | $6.3 | $6.93 | $6.19 | 507,883 | 06-20-2024 |
$6.8 | $7.44 | $6.8 | $7.44 | $6.7 | 357,874 | 06-19-2024 |
$6.8 | $7.44 | $6.8 | $7.44 | $6.7 | 357,874 | 06-18-2024 |
$7.47 | $7.81 | $7.47 | $8.02 | $7.45 | 114,296 | 06-17-2024 |
$7.9 | $8.31 | $7.9 | $8.44 | $7.81 | 97,998 | 06-14-2024 |
$8.51 | $7.94 | $8.51 | $8.71 | $7.93 | 238,780 | 06-13-2024 |
$7.93 | $7.83 | $7.93 | $7.98 | $7.47 | 167,224 | 06-12-2024 |
$7.51 | $7.75 | $7.51 | $7.92 | $7.4 | 203,229 | 06-11-2024 |
$7.82 | $7.7 | $7.82 | $7.93 | $7.52 | 394,580 | 06-10-2024 |
$8.06 | $7.59 | $8.06 | $8.535 | $7.59 | 178,417 | 06-07-2024 |
$7.72 | $7.8 | $7.72 | $8.21 | $7.5 | 100,990 | 06-06-2024 |
$7.77 | $7.83 | $7.77 | $7.87 | $7.71 | 100,629 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Solid Biosciences Inc. Company Name:
SLDB Stock Symbol:
NASDAQ Market:
Solid Biosciences Inc. Website:
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,847 restricted stock units (“...
CHARLESTOWN, Mass., July 01, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that the Company has been added to the broad-market Russell 3000 ® Index as ...
2024-06-21 08:15:07 ET Piper Sandler analyst issues OVERWEIGHT recommendation for SLDB on June 21, 2024 06:49AM ET. The previous analyst recommendation was Overweight. SLDB was trading at $6.3 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...